EQT Private Equity and Mubadala to Purchase Envirotainer


Transaction totals about $3 billion

The EQT X fund (EQT Private Equity), and Mubadala Investment Company have agreed to acquire Envirotainer—a provider of secure cold-chain solutions for the air transportation of pharmaceuticals—for approximately $3 billion. The deal is expected to close Q3 of this year.

The parties will seek to support Envirotainer in its next phase of growth by accelerating expansion in Asia-Pacific (APAC) and continuing growth in its other markets. They plan to help scale the newly launched CryoSure offering, while continuing the roll-out of the third-generation Releye platform.

“The temperature-controlled distribution of pharma products offers very attractive and thematic exposure to the fast-growing biopharma end-market,” says Ali Farahani, partner within EQT Private Equity’s advisory team. “Envirotainer is an integral part of the global pharmaceutical infrastructure … We continue to see significant growth potential ahead and are excited to partner with the management team to unlock the full potential together with our partners at Mubadala.”

Related Videos
Related Content
© 2024 MJH Life Sciences

All rights reserved.